China Measles Vaccine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Measles Vaccine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Measles Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Measles Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • GSK

    • Merck

    • Bavarian Nordic

    • CSL Limited

    • Sanofi-Pasteur

    • Emergent Biosolutions

    • Johnson & Johnson

    • Novartis

    • Medimmune

    • Pfizer

    • China National Biotech Group

    • Serum Institute of India

    By Type:

    • Mumps Measles Rubella Vaccine, Live (MMR-II)

    • Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

    By End-User:

    • Children

    • Adults

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Measles Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Measles Vaccine Market Size and Growth Rate of Mumps Measles Rubella Vaccine, Live (MMR-II) from 2016 to 2027

    • 1.3.2 China Measles Vaccine Market Size and Growth Rate of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Measles Vaccine Market Size and Growth Rate of Children from 2016 to 2027

    • 1.4.2 China Measles Vaccine Market Size and Growth Rate of Adults from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Measles Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Measles Vaccine by Major Types

    • 3.4.1 Market Size and Growth Rate of Mumps Measles Rubella Vaccine, Live (MMR-II)

    • 3.4.2 Market Size and Growth Rate of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

    4 Segmentation of Measles Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Measles Vaccine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Measles Vaccine in Children

    • 4.4.2 Market Size and Growth Rate of Measles Vaccine in Adults

    5 Market Analysis by Regions

    • 5.1 China Measles Vaccine Production Analysis by Regions

    • 5.2 China Measles Vaccine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Measles Vaccine Landscape Analysis

    • 6.1 North China Measles Vaccine Landscape Analysis by Major Types

    • 6.2 North China Measles Vaccine Landscape Analysis by Major End-Users

    7 Central China Measles Vaccine Landscape Analysis

    • 7.1 Central China Measles Vaccine Landscape Analysis by Major Types

    • 7.2 Central China Measles Vaccine Landscape Analysis by Major End-Users

    8 South China Measles Vaccine Landscape Analysis

    • 8.1 South China Measles Vaccine Landscape Analysis by Major Types

    • 8.2 South China Measles Vaccine Landscape Analysis by Major End-Users

    9 East China Measles Vaccine Landscape Analysis

    • 9.1 East China Measles Vaccine Landscape Analysis by Major Types

    • 9.2 East China Measles Vaccine Landscape Analysis by Major End-Users

    10 Northeast China Measles Vaccine Landscape Analysis

    • 10.1 Northeast China Measles Vaccine Landscape Analysis by Major Types

    • 10.2 Northeast China Measles Vaccine Landscape Analysis by Major End-Users

    11 Southwest China Measles Vaccine Landscape Analysis

    • 11.1 Southwest China Measles Vaccine Landscape Analysis by Major Types

    • 11.2 Southwest China Measles Vaccine Landscape Analysis by Major End-Users

    12 Northwest China Measles Vaccine Landscape Analysis

    • 12.1 Northwest China Measles Vaccine Landscape Analysis by Major Types

    • 12.2 Northwest China Measles Vaccine Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 GSK

      • 13.1.1 GSK Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Merck

      • 13.2.1 Merck Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Bavarian Nordic

      • 13.3.1 Bavarian Nordic Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 CSL Limited

      • 13.4.1 CSL Limited Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Sanofi-Pasteur

      • 13.5.1 Sanofi-Pasteur Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Emergent Biosolutions

      • 13.6.1 Emergent Biosolutions Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Johnson & Johnson

      • 13.7.1 Johnson & Johnson Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Novartis

      • 13.8.1 Novartis Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Medimmune

      • 13.9.1 Medimmune Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Pfizer

      • 13.10.1 Pfizer Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 China National Biotech Group

      • 13.11.1 China National Biotech Group Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Serum Institute of India

      • 13.12.1 Serum Institute of India Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Measles Vaccine Market Size and Growth Rate of Mumps Measles Rubella Vaccine, Live (MMR-II) from 2016 to 2027

    • Figure China Measles Vaccine Market Size and Growth Rate of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Measles Vaccine Market Size and Growth Rate of Children from 2016 to 2027

    • Figure China Measles Vaccine Market Size and Growth Rate of Adults from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Measles Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Measles Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Measles Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Measles Vaccine by Different Types from 2016 to 2027

    • Table Consumption Share of Measles Vaccine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Mumps Measles Rubella Vaccine, Live (MMR-II)

    • Figure Market Size and Growth Rate of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Measles Vaccine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Measles Vaccine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Children

    • Figure Market Size and Growth Rate of Adults

    • Table China Measles Vaccine Production by Regions

    • Table China Measles Vaccine Production Share by Regions

    • Figure China Measles Vaccine Production Share by Regions in 2016

    • Figure China Measles Vaccine Production Share by Regions in 2021

    • Figure China Measles Vaccine Production Share by Regions in 2027

    • Table China Measles Vaccine Consumption by Regions

    • Table China Measles Vaccine Consumption Share by Regions

    • Figure China Measles Vaccine Consumption Share by Regions in 2016

    • Figure China Measles Vaccine Consumption Share by Regions in 2021

    • Figure China Measles Vaccine Consumption Share by Regions in 2027

    • Table North China Measles Vaccine Consumption by Types from 2016 to 2027

    • Table North China Measles Vaccine Consumption Share by Types from 2016 to 2027

    • Figure North China Measles Vaccine Consumption Share by Types in 2016

    • Figure North China Measles Vaccine Consumption Share by Types in 2021

    • Figure North China Measles Vaccine Consumption Share by Types in 2027

    • Table North China Measles Vaccine Consumption by End-Users from 2016 to 2027

    • Table North China Measles Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure North China Measles Vaccine Consumption Share by End-Users in 2016

    • Figure North China Measles Vaccine Consumption Share by End-Users in 2021

    • Figure North China Measles Vaccine Consumption Share by End-Users in 2027

    • Table Central China Measles Vaccine Consumption by Types from 2016 to 2027

    • Table Central China Measles Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Central China Measles Vaccine Consumption Share by Types in 2016

    • Figure Central China Measles Vaccine Consumption Share by Types in 2021

    • Figure Central China Measles Vaccine Consumption Share by Types in 2027

    • Table Central China Measles Vaccine Consumption by End-Users from 2016 to 2027

    • Table Central China Measles Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Measles Vaccine Consumption Share by End-Users in 2016

    • Figure Central China Measles Vaccine Consumption Share by End-Users in 2021

    • Figure Central China Measles Vaccine Consumption Share by End-Users in 2027

    • Table South China Measles Vaccine Consumption by Types from 2016 to 2027

    • Table South China Measles Vaccine Consumption Share by Types from 2016 to 2027

    • Figure South China Measles Vaccine Consumption Share by Types in 2016

    • Figure South China Measles Vaccine Consumption Share by Types in 2021

    • Figure South China Measles Vaccine Consumption Share by Types in 2027

    • Table South China Measles Vaccine Consumption by End-Users from 2016 to 2027

    • Table South China Measles Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure South China Measles Vaccine Consumption Share by End-Users in 2016

    • Figure South China Measles Vaccine Consumption Share by End-Users in 2021

    • Figure South China Measles Vaccine Consumption Share by End-Users in 2027

    • Table East China Measles Vaccine Consumption by Types from 2016 to 2027

    • Table East China Measles Vaccine Consumption Share by Types from 2016 to 2027

    • Figure East China Measles Vaccine Consumption Share by Types in 2016

    • Figure East China Measles Vaccine Consumption Share by Types in 2021

    • Figure East China Measles Vaccine Consumption Share by Types in 2027

    • Table East China Measles Vaccine Consumption by End-Users from 2016 to 2027

    • Table East China Measles Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure East China Measles Vaccine Consumption Share by End-Users in 2016

    • Figure East China Measles Vaccine Consumption Share by End-Users in 2021

    • Figure East China Measles Vaccine Consumption Share by End-Users in 2027

    • Table Northeast China Measles Vaccine Consumption by Types from 2016 to 2027

    • Table Northeast China Measles Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Measles Vaccine Consumption Share by Types in 2016

    • Figure Northeast China Measles Vaccine Consumption Share by Types in 2021

    • Figure Northeast China Measles Vaccine Consumption Share by Types in 2027

    • Table Northeast China Measles Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northeast China Measles Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Measles Vaccine Consumption Share by End-Users in 2016

    • Figure Northeast China Measles Vaccine Consumption Share by End-Users in 2021

    • Figure Northeast China Measles Vaccine Consumption Share by End-Users in 2027

    • Table Southwest China Measles Vaccine Consumption by Types from 2016 to 2027

    • Table Southwest China Measles Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Measles Vaccine Consumption Share by Types in 2016

    • Figure Southwest China Measles Vaccine Consumption Share by Types in 2021

    • Figure Southwest China Measles Vaccine Consumption Share by Types in 2027

    • Table Southwest China Measles Vaccine Consumption by End-Users from 2016 to 2027

    • Table Southwest China Measles Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Measles Vaccine Consumption Share by End-Users in 2016

    • Figure Southwest China Measles Vaccine Consumption Share by End-Users in 2021

    • Figure Southwest China Measles Vaccine Consumption Share by End-Users in 2027

    • Table Northwest China Measles Vaccine Consumption by Types from 2016 to 2027

    • Table Northwest China Measles Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Measles Vaccine Consumption Share by Types in 2016

    • Figure Northwest China Measles Vaccine Consumption Share by Types in 2021

    • Figure Northwest China Measles Vaccine Consumption Share by Types in 2027

    • Table Northwest China Measles Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northwest China Measles Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Measles Vaccine Consumption Share by End-Users in 2016

    • Figure Northwest China Measles Vaccine Consumption Share by End-Users in 2021

    • Figure Northwest China Measles Vaccine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Bavarian Nordic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bavarian Nordic

    • Figure Sales and Growth Rate Analysis of Bavarian Nordic

    • Figure Revenue and Market Share Analysis of Bavarian Nordic

    • Table Product and Service Introduction of Bavarian Nordic

    • Table Company Profile and Development Status of CSL Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Limited

    • Figure Sales and Growth Rate Analysis of CSL Limited

    • Figure Revenue and Market Share Analysis of CSL Limited

    • Table Product and Service Introduction of CSL Limited

    • Table Company Profile and Development Status of Sanofi-Pasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Pasteur

    • Figure Sales and Growth Rate Analysis of Sanofi-Pasteur

    • Figure Revenue and Market Share Analysis of Sanofi-Pasteur

    • Table Product and Service Introduction of Sanofi-Pasteur

    • Table Company Profile and Development Status of Emergent Biosolutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent Biosolutions

    • Figure Sales and Growth Rate Analysis of Emergent Biosolutions

    • Figure Revenue and Market Share Analysis of Emergent Biosolutions

    • Table Product and Service Introduction of Emergent Biosolutions

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Medimmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medimmune

    • Figure Sales and Growth Rate Analysis of Medimmune

    • Figure Revenue and Market Share Analysis of Medimmune

    • Table Product and Service Introduction of Medimmune

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of China National Biotech Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China National Biotech Group

    • Figure Sales and Growth Rate Analysis of China National Biotech Group

    • Figure Revenue and Market Share Analysis of China National Biotech Group

    • Table Product and Service Introduction of China National Biotech Group

    • Table Company Profile and Development Status of Serum Institute of India

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India

    • Figure Sales and Growth Rate Analysis of Serum Institute of India

    • Figure Revenue and Market Share Analysis of Serum Institute of India

    • Table Product and Service Introduction of Serum Institute of India


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.